Effects of mitofusin-2 gene on cell proliferation and chemotherapy sensitivity of MCF-7

Abstract

In order to evaluate the effect of mitofusin-2 gene (mfn2) on proliferation and chemotherapy sensitivity of human breast carcinoma cell line MCF-7 in vitro, pEGFPmfn2 plasmid carrying full length of mitofusin-2 gene was transfected, by using sofast, into MCF-7 cells. Mitofusin-2 gene expression in MCF-7 cells transfected by sofast after 48 h was detected by PCR and Western blotting, and the stable expression of GFP protein in MCF-7 cells by Western blot analysis. The proliferation of MCF-7 cells was assayed by MTT and cell counting. By using PI method, the effects of mfn2 on the cell cycle distribution of MCF-7 were measured. Annexin-V/PI double labeling method was employed to detect the changes in apoptosis induced by chemotherapeutics before and after transfection. The results showed that the MCF-7 cells transfected with mfn2 gene could stably and highly express GFP protein. MTT assay revealed that after transfection of mfn2 cDNA, the proliferation of MCF-7 cells was significantly inhibited. DNA histogram showed that cells arrested in S phase, and the percentage of S phase cells was 42.7, 17.2 and 19.6 in mfn2 cDNA transfection group, blank plasmid transfection group and blank control group, respectively (P<0.05). The apoptosis ratio of the cells transfected with mfn2 gene was increased from 3.56% to 15.95%, that of the cells treated with camptothecin (CAMP) followed by mfn2 gene transfection was 69.6%, and that in blank plasmid transfection group and blank control group was 31.0% and 23.4% respectively (P<0.05). It was suggested that transfection of mfn2 gene could significantly inhibit the proliferation of MCF-7 cells and promote their sensitivity to CAMP with a synergic effect.

Keywords

mitofusin-2 gene / MCF-7 / cell proliferation / chemotherapy sensitivity

References

[1] SantelA., FrankS., GaumeB., et al.. Get the balance right: Mitofusins roles in health and disease. Biochim. Biophys Acta, 2006, 1763(5–6): 490-499

[2] ChenK., GuoX., MaD., et al.. Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol, 2004, 6(9): 872-883

[3] GongJ., TraganoF., DarzynkiewiczZ., et al.. Discrimination of G2 and mitotic cells by flow cytometry based on different expression of cyclins A and B1. Exp Cell Res, 1995, 220: 226-231

[4] SantelA., FullerM. T.. Control of mitochondrial morphology by a human mitofusin. J Cell Sci, 2001, 114(5): 867-874

[5] RojoM., LegrosF., ChateauD., et al.. Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. J Cell Sci, 2002, 115(8): 1663-1674

[6] KarbowskiM., LeeY. J., GaumeB., et al.. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J Cell Biol, 2002, 159(6): 931-938

[7] ChenH., DetmerS. A., EwaldA. J., et al.. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol, 2003, 160(2): 189-200

[8] DelmasC., ManentiS., BoudjelalA., et al.. The p42/p44 mitogen-activated protein kinase activation triggers p27kip1 degradation independently of cdk2/cyclin E in NIH 3T3 cells. J Biol Chem, 2001, 276(37): 34958-34965

[9] LeoneG., DeGregoriJ., SearsR., et al.. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature, 1997, 387(6631): 422-426

[10] van-der BruggenP., TraversariC., ChomezP., et al.. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 1991, 254(5038): 1643-1647